Cynthia M. Butitta, Chief Operating Officer at Kite Pharma, Inc. (KITE), sold 20,000 shares at $51.28 ($1.0M) on 2016-06-23, disclosed to the SEC on 2016-06-27.
Open-market sale of $1.0M KITE by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $51.28 | 10,000 | $513K | 50.6% |
| 2 | $50.15 | 10,000 | $501K | 49.4% |
| Total | $50.71 avg | 20,000 | $1.0M | 100% |
| Filing → |
| KITE | SELL | 2017-07-11 | $1.5M | — | Filing → |
| KITE | SELL | 2017-06-27 | $711K | — | Filing → |
| KITE | SELL | 2017-06-12 | $885K | — | Filing → |